BCL9 (NM_004326) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC219304L1V

Lenti ORF particles, BCL9 (Myc-DDK-tagged)-Human B-cell CLL/lymphoma 9 (BCL9), 200ul, >10^7 TU/mL

Specifications

Product Data

• Type: Human Tagged ORF Clone Lentiviral Particle
• Tag: Myc-DDK
• Symbol: BCL9
• Synonyms: LGS
• Mammalian Cell Selection: None
• Vector: pLenti-C-Myc-DDK
• ACCN: NM_004326
• ORF Size: 4278 bp
• Sequence Data:
  ORF Nucleotide Sequence

  The ORF insert of this clone is exactly the same as(RC219304).
• OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
• OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.

Reference Data

• RefSeq: NM_004326.2
• RefSeq Size: 6278 bp
• RefSeq ORF: 4281 bp
• Locus ID: 607
• UniProt ID: O00512
• Cytogenetics: 1q21.2
• Protein Families: Druggable Genome
• MW: 149.1 kDa
• Gene Summary: BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008]